Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. covers the month of September 2026. The report addresses significant corporate governance developments, including disputes with dissident shareholders regarding the September 4, 2026 Annual General Meeting and the resignation of two board members.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate events and does not contain financial performance data.
Material Changes
- Shareholder Disputes: Dissident shareholders L.I.A. Pure Capital Ltd. and Invest Pro Shukai Hon Ltd. challenged the voting results of the September 4, 2026 Annual General Meeting.
- Tender Offer Notice: On September 8, 2026, the dissident shareholders notified the Company of their intention to initiate a special tender offer under Section 328 of the Israeli Companies Law.
- Board Resignations: On September 9, 2026, Mr. Yoshinori Oikawa and Dr. Yael Margolin resigned from the Board of Directors. The Company stated these resignations were not related to any disagreement regarding operations, policies, or practices.
Outlook, Risks, and Management Commentary
Management is currently conducting discussions with the dissident shareholders to resolve the matters concerning the voting results and the proposed tender offer. The filing incorporates this information by reference into the Company's registration statements on Form F-3 and Form S-8. No specific financial guidance or operational outlook was provided in this text.
Key Facts for Investor Verification
- Verify the status of the special tender offer initiated by dissident shareholders under Israeli law.
- Confirm the outcome of the ongoing discussions between management and dissident shareholders regarding the September 4 meeting results.
- Monitor the Board of Directors' composition following the resignations of Mr. Oikawa and Dr. Margolin.
- Check subsequent filings for any financial impact resulting from these corporate governance events.